Résultats de recherche

“My job is to be a guardian of patient safety.”As Safety Science Director, she works across both early development and post-marketing, ensuring that risks are anticipated, analyzed, and managed so treatments can reach patients responsibly....

New in our A Life in Science series, we hear from Mary Jane Hinrichs, Senior Vice President and Head of Early Development, about her path from discovering a passion for pharmacology to leading drug candidates through first-in-human trials. She shares how...

An article by Dr Marius Tham, Director Global Medical Affairs, Ipsen ...

By Christelle Huguet, EVP & Head of R&D, Ipsen...

“All medicines have side effects, but it's just about trying to minimize the impact through providing the information patients and clinicians need or finding other ways to mitigate that impact.” — Jacintha Sivarajah ...

Ivan Diaz-Padilla, Senior Vice President and Global Head, Oncology Therapeutic Area Unit, R&D at Ipsen, shares his vision for building a balanced and sustainable pipeline powered by bold science....

“We need to make sure that it’s scalable, safe, and reproducible—so that every patient gets the same medicine every time.”  ...

« Nous devons nous assurer que c’est industrialisable, sûr et reproductible — afin que chaque patient reçoive le même médicament à chaque fois. » ...

....

....